Access to harm reduction programs among persons who inject drugs: Findings from a respondent-driven sampling survey in Tehran, Iran

International Journal of Drug Policy

Volumn 25, Issue 4, 2014, Pages 717-723

  Rahnama, Ruyan ^a   Mohraz, Minoo ^b   Mirzazadeh, Ali ^a   Rutherford, George ^a,c   McFarland, Willi ^d   Akbari, Gholamreza ^b   Malekinejad, Mohsen ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Harm reduction; HIV; Injection drug use; Iran; Methadone; Needle exchange programs; Respondent driven sampling

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEALTH CARE ACCESS; HIGH RISK BEHAVIOR; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PRISON; RESIDENTIAL AREA; AGE; HARM REDUCTION; HEALTH CARE DELIVERY; HEALTH SERVICE; HIV INFECTIONS; MIDDLE AGED; PATIENT ATTITUDE; PREVENTION AND CONTROL; QUESTIONNAIRE; SEX DIFFERENCE; SUBSTANCE ABUSE; UTILIZATION;

ADULT; AGE FACTORS; FEMALE; HARM REDUCTION; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; RISK-TAKING; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH SERVICES;

EID: 84906056029     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.05.013     Document Type: Article

References (22)

1. Dolan K., Salimi S., Nassirimanesh B., Mohsenifar S., Allsop D., Mokri A., et al. Characteristics of Iranian women seeking drug treatment. Journal of Women's Health (Larchmt) 2011, 20(11):1687-1691.
2. Emran R., Nassirimanesh B., Afshar P., Ohiri K., Claeson M., Power R., et al. HIV/AIDS harm reduction in Iran. The Lancet 2006, August, 368(9534):434-435.
3. Mahfoud Z., Afifi R., Ramia S., Khoury D., Kassak K., El Barbir F., et al. HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: Results of the first biobehavioral surveys. AIDS 2010, 24(Suppl. 2):S45-S54.
4. Malekinejad, M. (2008). Assessment of the use of respondent-driven sampling for studying populations most at risk of HIV infection (Doctoral dissertation). Dr. P.H, University of California.
5. Malekinejad M., Vazirian M. Transition to injection amongst opioid users in Iran: Implications for harm reduction. International Journal of Drug Policy 2012, 23(4):333-337.
6. MAP Network The Status and Trends of HIV/AIDS/STI Epidemics in Asia and the Pacific. Monitoring the AIDS Pandemic (MAP) Provisional Report 2001.
7. McCreesh N., Frost S.D., Seeley J., Katongole J., Tarsh M.N., Ndunguse R., et al. Evaluation of respondent-driven sampling. Epidemiology 2012, 23(1):138-147.
8. Ministry of Health and Medical Education Islamic Republic of Iran Progress Report: On Monitoring of the United Nations Special Session on HIV and AIDS 2012, National AIDS Committee Secretariat.
9. Mokri A., Schottenfeld R. Drug abuse and HIV transmission in Iran - Responding to public health challenges. Public health aspects of HIV/AIDS in low and middle income countries: Epidemiology, prevention and care 2008, 583-599. Springer, New York, USA. David Celentano, Chris Beyrer (Eds.).
10. Nissaramanesh B., Trace M., Roberts M., et al. The risk of harm reduction in the Islamic Republic of Iran. Briefing Paper 8: The Beckley Foundation Drug Policy Programme 2005.
11. Noroozi A., Shamshiri A., Gilanipour M., Ahmadzad Asl M., Saberi Zafarghandi M., Naserbahkt M., et al. Geographical distribution of mental, social, and addiction in 2007: Substance use version 2007, Iranian Ministry of Health and Medical Education, Office of Mental and Social Health and Addiction, Tehran.
12. Petersen Z., Myers B., van Hout M., Plüddemann A., Parry C., et al. Availability of HIV prevention and treatment services for people who inject drugs: Findings from 21 countries. Harm Reduction Journal 2013, August, 19(10):13.
13. Rahimi-Movaghar A., Amin-Esmaeili M., Haghdoost A., Sadeghirad B., Mohraz M., et al. HIV prevalence amongst injecting drug users in Iran: A systematic review of studies conducted during the decade 1998-2007. International Journal of Drug Policy 2012, July, 23(4):271-278.
14. Razani N., Mohraz M., Kheirandish P., Malekinejad M., Malekafzali H., Mokri A., et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction 2007, 102(9):1472-1482.
15. Razzaghi E., Rahimi A., Hossen M., Madani S., et al. Rapid assessment of drug misuse in Iran, Tehran 1998-1999 2000, Iranian Welfare Organization Press, Tehran.
16. Razzaghi E.M., Movaghar A.R., Green T.C., Khoshnood K., et al. Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduction Journal 2006, 3:12.
17. Richter L., Johnson P.B. Current methods of assessing substance use: A review of strengths, problems, and developments. Journal of Drug Issues 2001, 31(4):809-832.
18. Rudolph A.E., Fuller C.M., Latkin C., et al. The importance of measuring and accounting for potential biases in respondent-driven samples. AIDS and Behavior 2013, 17(6):2244-2252.
19. Shawky S., Soliman C., Kassak K.M., Oraby D., El-Khoury D., Kabore I., et al. HIV surveillance and epidemic profile in the Middle East and North Africa. Journal of Acquired Immune Deficiency Syndromes 2009, 51(Suppl. 3):S83-S95.
20. Tait R. Iran faces up to its most lethal threat-drugs. The Guardian 2005, Wednesday 26 October 2005. Retrieved 11th June 2014 from http://www.theguardian.com/world/2005/oct/27/iran.roberttait.
21. Vazirian M., Nassirimanesh B., Zamani S., Ono-Kihara M., Vazirian M., Ravari S.M., et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduction Journal 2005, 2:19.
22. WHO Regional Office for the Eastern Mediterranean Best practice in HIV/AIDS prevention and care for injecting drug abusers: The triangular clinic in Kermanshah, Islamic Republic of Iran 2004.